Sun Pharma Advanced Research Co

Sun Pharma Advanced Research Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sun Pharma Advanced Research Co (SPARC.NS) as of Oct 10, 2026 is 15.89 B INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -3.21 B INR — a change of -594.34% (higher).

EBITDA

15.89 BINR

YoY

-594.34%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sun Pharma Advanced Research Co is 2026 15.89 B INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sun Pharma Advanced Research Co was 2025 -3.21 B INR. It decreases by -594.34% higher compared to the previous year.

The Sun Pharma Advanced Research Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-1.45 B INR
Jan 1, 2020
-3.05 B INR
Jan 1, 2021
-1.30 B INR
Jan 1, 2022
-1.80 B INR
Jan 1, 2023
-2.12 B INR
Jan 1, 2024
-3.99 B INR
Jan 1, 2025
-3.21 B INR
Jan 1, 2026
15.89 B INR
The Sun Pharma Advanced Research Co EBITDA history
YEAREBITDAYoY
15.89 BINR-594.34%
-3.21 BINR-19.46%
-3.99 BINR+88.32%
-2.12 BINR+17.77%
-1.80 BINR+38.85%
-1.30 BINR-57.58%
-3.05 BINR+111.30%
-1.45 BINR-40.41%
-2.43 BINR+97.24%
-1.23 BINR+96.58%
-625.67 MINR+80.35%
-346.91 MINR-202.68%
337.86 MINR—
Access this data via the Eulerpool API
Get Free API Key

Sun Pharma Advanced Research Co Stock analysis

What does Sun Pharma Advanced Research Co do? Sun Pharma Advanced Research Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sun Pharma Advanced Research Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sun Pharma Advanced Research Co is 15.89 B INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sun Pharma Advanced Research Co changed from -3.21 B INR to 15.89 B INR, representing a -594.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Sun Pharma Advanced Research Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Sun Pharma Advanced Research Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Sun Pharma Advanced Research Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sun Pharma Advanced Research Co